Tian, Yuan
Chen, Xiao-min
Liang, Xian-ming
Wu, Xiao-bin
Yao, Chun-meng
Clinical trials referenced in this document:
Documents that mention this clinical trial
SGLT2 inhibitors attenuate nephrin loss and enhance TGF-β1 secretion in type 2 diabetes patients with albuminuria: a randomized clinical trial
https://doi.org/10.1038/s41598-022-19988-7
Funding for this research was provided by:
Science and Technology Benefit Fund from Xiamen Municipal Bureau of Science and Technology (3502Z20184039)
Article History
Received: 15 June 2022
Accepted: 7 September 2022
First Online: 20 September 2022
Competing interests
: The authors declare no competing interests.